Molecular basis for the dosing time-dependency of anti-allodynic effects of gabapentin in a mouse model of neuropathic pain

Molecular Pain

Volumn 6, Issue , 2010, Pages

  Kusunose, Naoki ^a   Koyanagi, Satoru ^a   Hamamura, Kengo ^a   Matsunaga, Naoya ^a   Yoshida, Miyako ^b   Uchida, Takahiro ^b   Tsuda, Makoto ^a   Inoue, Kazuhide ^a   Ohdo, Shigehiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL ALPHA2DELTA 1 SUBUNIT; GABAPENTIN; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID; AMINE; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; PROTEIN SUBUNIT;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DOSE RESPONSE; DRUG BINDING; DRUG BLOOD LEVEL; DRUG EFFICACY; MALE; MOLECULAR DYNAMICS; MOUSE; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCIATIC NERVE; SPINAL GANGLION; TISSUE LEVEL; UPREGULATION; WITHDRAWAL REFLEX; ANIMAL; DISEASE MODEL; DRUG ADMINISTRATION; DRUG EFFECT; HYPERALGESIA; NEURALGIA; PHYSIOLOGY; TIME;

AMINES; ANIMALS; CALCIUM CHANNELS; CIRCADIAN RHYTHM; CYCLOHEXANECARBOXYLIC ACIDS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; GAMMA-AMINOBUTYRIC ACID; HYPERALGESIA; MICE; NEURALGIA; PROTEIN SUBUNITS; TIME FACTORS;

EID: 78649335631     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-6-83     Document Type: Article

References (32)

1. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999, 353:1959-1964. 10.1016/S0140-6736(99)01307-0, 10371588.
2. Tsuda M, Inoue K, Salter MW. Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia. Trends Neurosci 2005, 28:101-107. 10.1016/j.tins.2004.12.002, 15667933.
3. Backonja M, Glanzman RL. Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials. Clin Ther 2003, 25:81-104. 10.1016/S0149-2918(03)90011-7, 12637113.
4. McLean MJ. Gabapentin in the management of convulsive disorders. Epilepsia 1999, 40(Suppl 6):S39-50. discussion S73-4, 10.1111/j.1528-1157.1999.tb00932.x, 10530682.
5. Fink K, Meder W, Dooley DJ, Gothert M. Inhibition of neuronal Ca(2+) influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices. Br J Pharmacol 2000, 130:900-906. 10.1038/sj.bjp.0703380, 1572136, 10864898.
6. van Hooft JA, Dougherty JJ, Endeman D, Nichols RA, Wadman WJ. Gabapentin inhibits presynaptic Ca(2+) influx and synaptic transmission in rat hippocampus and neocortex. Eur J Pharmacol 2002, 449:221-228. 10.1016/S0014-2999(02)02044-7, 12167463.
7. Li CY, Song YH, Higuera ES, Luo ZD. Spinal dorsal horn calcium channel alpha2delta-1 subunit upregulation contributes to peripheral nerve injury-induced tactile allodynia. J Neurosci 2004, 24:8494-8499. 10.1523/JNEUROSCI.2982-04.2004, 1635787, 15456823.
8. Luo ZD, Calcutt NA, Higuera ES, Valder CR, Song YH, Svensson CI, Myers RR. Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. J Pharmacol Exp Ther 2002, 303:1199-1205. 10.1124/jpet.102.041574, 12438544.
9. Luo ZD, Chaplan SR, Higuera ES, Sorkin LS, Stauderman KA, Williams ME, Yaksh TL. Upregulation of dorsal root ganglion (alpha)2(delta) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. J Neurosci 2001, 21:1868-1875.
10. Fink K, Dooley DJ, Meder WP, Suman-Chauhan N, Duffy S, Clusmann H, Gothert M. Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology 2002, 42:229-236. 10.1016/S0028-3908(01)00172-1, 11804619.
11. Gee NS, Brown JP, Dissanayake VU, Offord J, Thurlow R, Woodruff GN. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem 1996, 271:5768-5776. 10.1074/jbc.271.10.5768, 8621444.
12. Hendrich J, Van Minh AT, Heblich F, Nieto-Rostro M, Watschinger K, Striessnig J, Wratten J, Davies A, Dolphin AC. Pharmacological disruption of calcium channel trafficking by the alpha2delta ligand gabapentin. Proc Nat Acad Sci USA 2008, 105:3628-3633. 10.1073/pnas.0708930105, 2265195, 18299583.
13. O'Connor AB, Dworkin RH. Treatment of neuropathic pain: An overview of recent guidelines. Am J Med 2009, 122:S22-32. 10.1016/j.amjmed.2009.04.007, 19801049.
14. Turan A, White PF, Karamanlioglu B, Memis D, Tasdogan M, Pamukcu Z, Yavuz E. Gabapentin: an alternative to the cyclooxygenase-2 inhibitors for perioperative pain management. Anesth Analg 2006, 102:175-181. 10.1213/01.ane.0000184824.43411.63, 16368826.
15. Gachon F, Nagoshi E, Brown SA, Ripperger J, Schibler U. The mammalian circadian timing system: from gene expression to physiology. Chromosoma 2004, 113:103-112. 10.1007/s00412-004-0296-2, 15338234.
16. Lemmer B. Chronopharmacology and controlled drug release. Expert Opin Drug Deliv 2005, 2:667-681. 10.1517/17425247.2.4.667, 16296793.
17. Ohdo S, Koyanagi S, Suyama H, Higuchi S, Aramaki H. Changing the dosing schedule minimizes the disruptive effects of interferon on clock function. Nat Med 2001, 7:356-360. 10.1038/85507, 11231636.
18. Narita M, Nakajima M, Miyoshi K, Narita M, Nagumo Y, Miyatake M, Yajima Y, Yanagida K, Yamazaki M, Suzuki T. Role of spinal voltage-dependent calcium channel alpha 2 delta-1 subunit in the expression of a neuropathic pain-like state in mice. Life Sci 2007, 80:2015-2024. 10.1016/j.lfs.2007.02.045, 17442347.
19. Jarjour NN. Circadian variation in allergen and nonspecific bronchial responsiveness in asthma. Chronobiol Int 1999, 16:631-639. 10.3109/07420529908998732, 10513886.
20. Burioka N, Sako T, Tomita K, Miyata M, Suyama H, Igishi T, Shimizu E. Theophylline chronotherapy of nocturnal asthma using bathyphase of circadian rhythm in peak expiratory flow rate. Biomed Pharmacother 2001, 55(Suppl 1):142s-146s.
21. Merki HS, Wilder-Smith C, Halter F. Treatment with H2-Receptor Antagonists: When Is the Best Time to Dose?. Scand J Gastroenterol 1988, 23:15-22.
22. Bellamy N, Sothern RB, Campbell J. Rhythmic variations in pain perception in osteoarthritis of the knee. J Rheumatol 1990, 17:364-372.
23. Kowanko IC, Knapp MS, Pownall R, Swannell AJ. Domiciliary self-measurement in the rheumatoid arthritis and the demonstration of circadian rhythmicity. Ann Rheum Dis 1982, 41:453-455. 10.1136/ard.41.5.453, 1001020, 7125713.
24. Odrcich M, Bailey JM, Cahill CM, Gilron I. Chronobiological characteristics of painful diabetic neuropathy and postherpetic neuralgia: diurnal pain variation and effects of analgesic therapy. Pain 2006, 120:207-212. 10.1016/j.pain.2005.10.007, 16359793.
25. Matsunaga N, Ikeda M, Takiguchi T, Koyanagi S, Ohdo S. The molecular mechanism regulating 24-hour rhythm of CYP2E1 expression in the mouse liver. Hepatology 2008, 48:240-251. 10.1002/hep.22304, 18537186.
26. Murakami Y, Higashi Y, Matsunaga N, Koyanagi S, Ohdo S. Circadian clock-controlled intestinal expression of the multidrug-resistance gene mdr1a in mice. Gastroenterology 2008, 135:1636-1644. e3, 10.1053/j.gastro.2008.07.073, 18773899.
27. Su TZ, Lunney E, Campbell G, Oxender DL. Transport of gabapentin, a gamma-amino acid drug, by system l alpha-amino acid transporters: a comparative study in astrocytes, synaptosomes, and CHO cells. J Neurochem 1995, 64:2125-2131. 10.1046/j.1471-4159.1995.64052125.x, 7722496.
28. Marais E, Klugbauer N, Hofmann F. Calcium channel alpha(2)delta subunits-structure and Gabapentin binding. Mol Pharmacol 2001, 59:1243-1248.
29. Qin N, Yagel S, Momplaisir ML, Codd EE, D'Andrea MR. Molecular cloning and characterization of the human voltage-gated calcium channel alpha(2)delta-4 subunit. Mol Pharmacol 2002, 62:485-496. 10.1124/mol.62.3.485, 12181424.
30. Gong HC, Hang J, Kohler W, Li L, Su TZ. Tissue-specific expression and gabapentin-binding properties of calcium channel alpha2delta subunit subtypes. J Membr Biol 2001, 184:35-43. 10.1007/s00232-001-0072-7, 11687876.
31. Li CY, Zhang XL, Matthews EA, Li KW, Kurwa A, Boroujerdi A, Gross J, Gold MS, Dickenson AH, Feng G, Luo ZD. Calcium channel alpha2delta1 subunit mediates spinal hyperexcitability in pain modulation. Pain 2006, 125:20-34. 10.1016/j.pain.2006.04.022, 1635965, 16764990.
32. Vermeij TA, Edelbroek PM. Simultaneous high-performance liquid chromatographic analysis of pregabalin, gabapentin and vigabatrin in human serum by precolumn derivatization with o-phtaldialdehyde and fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci 2004, 810:297-303.